Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil

BACKGROUND: Donepezil is approved for treatment of dementia of the Alzheimer type and is currently available only in tablet forms in the United States. OBJECTIVE: To compare steady-state pharmacokinetics of once-weekly 10-mg/d and 5-mg/d Corplex™ donepezil transdermal delivery systems (TDS) with onc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tariot, Pierre N., Braeckman, Rene, Oh, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661317/
https://www.ncbi.nlm.nih.gov/pubmed/36120781
http://dx.doi.org/10.3233/JAD-220530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661317/
https://www.ncbi.nlm.nih.gov/pubmed/36120781
http://dx.doi.org/10.3233/JAD-220530

Ejemplares similares